BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15803360)

  • 1. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
    Rakovitch E; Pignol JP; Chartier C; Ezer M; Verma S; Dranitsaris G; Clemons M
    Breast Cancer Res Treat; 2005 Mar; 90(2):139-48. PubMed ID: 15803360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study.
    Helyer LK; Chin S; Chui BK; Fitzgerald B; Verma S; Rakovitch E; Dranitsaris G; Clemons M
    BMC Cancer; 2006 Feb; 6():39. PubMed ID: 16504038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
    Pedersen CG; Christensen S; Jensen AB; Zachariae R
    Eur J Cancer; 2009 Dec; 45(18):3172-81. PubMed ID: 19811905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary medicine use among women enrolled in a genetic testing program.
    DiGianni LM; Kim HT; Emmons K; Gelman R; Kalkbrenner KJ; Garber JE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):321-6. PubMed ID: 12692106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
    Wyatt G; Sikorskii A; Wills CE; Su H
    Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of the use of complementary and alternative medicine in women with metastatic cancer.
    Yildirim Y
    Cancer Nurs; 2010; 33(3):194-200. PubMed ID: 20357652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A test of the self-help model and use of complementary and alternative medicine among Hispanic women during treatment for breast cancer.
    Owens B
    Oncol Nurs Forum; 2007 Jul; 34(4):E42-50. PubMed ID: 17723972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide survey on complementary and alternative medicine in cancer patients in Japan.
    Hyodo I; Amano N; Eguchi K; Narabayashi M; Imanishi J; Hirai M; Nakano T; Takashima S
    J Clin Oncol; 2005 Apr; 23(12):2645-54. PubMed ID: 15728227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.
    Montazeri A; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):144-9. PubMed ID: 17371423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations.
    Digianni LM; Rue M; Emmons K; Garber JE
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):70-5. PubMed ID: 16434589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of prescription medications and complementary and alternative medicines to treat depressive and anxiety symptoms: results from a community sample.
    Parslow RA; Jorm AF
    J Affect Disord; 2004 Oct; 82(1):77-84. PubMed ID: 15465579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
    Chrystal K; Allan S; Forgeson G; Isaacs R
    N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of complementary and alternative medicine among women with gynecologic cancers.
    Swisher EM; Cohn DE; Goff BA; Parham J; Herzog TJ; Rader JS; Mutch DG
    Gynecol Oncol; 2002 Mar; 84(3):363-7. PubMed ID: 11855870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medications consumed by renal patients in southern Germany.
    Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R
    J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
    Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
    Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.